100 related articles for article (PubMed ID: 1893937)
1. Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma.
Schrijvers AH; Gerretsen M; Fritz JM; van Walsum M; Quak JJ; Snow GB; van Dongen GA
Exp Cell Res; 1991 Oct; 196(2):264-9. PubMed ID: 1893937
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
[TBL] [Abstract][Full Text] [Related]
3. The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion.
Brakenhoff RH; Gerretsen M; Knippels EM; van Dijk M; van Essen H; Weghuis DO; Sinke RJ; Snow GB; van Dongen GA
J Cell Biol; 1995 Jun; 129(6):1677-89. PubMed ID: 7790363
[TBL] [Abstract][Full Text] [Related]
4. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
Schrijvers AH; Quak JJ; Uyterlinde AM; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Sep; 53(18):4383-90. PubMed ID: 8364934
[TBL] [Abstract][Full Text] [Related]
5. Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48.
Quak JJ; Gerretsen M; Schrijvers AH; Meijer CJ; van Dongen GA; Snow GB
Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1287-91. PubMed ID: 1747235
[TBL] [Abstract][Full Text] [Related]
6. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
[TBL] [Abstract][Full Text] [Related]
7. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
[TBL] [Abstract][Full Text] [Related]
8. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.
Folli S; Westermann P; Braichotte D; Pèlegrin A; Wagnières G; van den Bergh H; Mach JP
Cancer Res; 1994 May; 54(10):2643-9. PubMed ID: 8168092
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.
Brakenhoff RH; van Gog FB; Looney JE; van Walsum M; Snow GB; van Dongen GA
Cancer Immunol Immunother; 1995 Mar; 40(3):191-200. PubMed ID: 7728778
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
[TBL] [Abstract][Full Text] [Related]
11. Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984.
Schrijvers AH; Gerretsen M; van Walsum M; Braakhuis BJ; Quak JJ; Snow GB; van Dongen GA
Cancer Immunol Immunother; 1992; 34(4):252-8. PubMed ID: 1371426
[TBL] [Abstract][Full Text] [Related]
12. Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells.
Eshel R; Zanin A; Kapon D; Sagi-Assif O; Brakenhoff R; van Dongen G; Witz IP
Int J Cancer; 2002 Apr; 98(6):803-10. PubMed ID: 11948455
[TBL] [Abstract][Full Text] [Related]
13. The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells.
Eshel R; Zanin A; Sagi-Assif O; Meshel T; Smorodinsky NI; Dwir O; Alon R; Brakenhoff R; van Dongen G; Witz IP
J Biol Chem; 2000 Apr; 275(17):12833-40. PubMed ID: 10777581
[TBL] [Abstract][Full Text] [Related]
14. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.
Brakenhoff RH; Stroomer JG; ten Brink C; de Bree R; Weima SM; Snow GB; van Dongen GA
Clin Cancer Res; 1999 Apr; 5(4):725-32. PubMed ID: 10213205
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody KIS-1 recognizing a new membrane antigen on human squamous-cell carcinoma.
Toh U; Yamana H; Fujita H; Toh Y; Fujii T; Kubo K; Yamada A; Shichijo S; Itoh K
Int J Cancer; 1996 May; 66(5):600-6. PubMed ID: 8647619
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ep-CAM, but not of E48, associates with nodal involvement in advanced squamous cell carcinomas of the larynx.
Romeu C; Farré X; Cardesa A; Nadal A
Histopathology; 2013 May; 62(6):954-61. PubMed ID: 23672314
[TBL] [Abstract][Full Text] [Related]
17. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9.
Kimmel KA; Carey TE
Cancer Res; 1986 Jul; 46(7):3614-23. PubMed ID: 3708592
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.
de Nooij-van Dalen AG; van Dongen GA; Smeets SJ; Nieuwenhuis EJ; Stigter-van Walsum M; Snow GB; Brakenhoff RH
Int J Cancer; 2003 Mar; 103(6):768-74. PubMed ID: 12516096
[TBL] [Abstract][Full Text] [Related]
19. Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.
de Bree R; Roos JC; Plaizier MA; Quak JJ; van Kamp GJ; den Hollander W; Snow GB; van Dongen GA
Br J Cancer; 1997; 75(7):1049-60. PubMed ID: 9083342
[TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomas.
Quak JJ; Schrijvers HG; Brakkee JG; Davis HD; Scheper RJ; Meijer CJ; Snow GB; Van Dongen GA
Int J Cancer; 1992 Feb; 50(4):507-13. PubMed ID: 1537614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
